XML 24 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
Basis of Presentation and Significant Accounting Policies (Tables)
9 Months Ended
Jun. 30, 2017
Accounting Policies [Abstract]  
Financing Receivables
Financing receivables consist of the following (in thousands):
 
June 30,
2017
 
September 30, 2016
Investment in sales-type lease
$
495

 
$

Support contract receivable
358

 

 
$
853

 
$

Inventory
Inventory consists of the following (in thousands):
 
June 30,
2017
 
September 30, 2016
Raw materials and supplies
$
158

 
$
149

Finished goods
961

 
1,755

 
$
1,119

 
$
1,904

Fair Value, Liabilities Measured on Recurring Basis
Financial liabilities measured at fair value on a reoccurring basis are summarized below (in thousands):
June 30, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total Fair Value
Derivative liability
 

 
25

 

 
25

 
 
$

 
$
25

 
$

 
$
25

September 30, 2016
 
Level 1
 
Level 2
 
Level 3
 
Total Fair Value
Derivative liability
 

 
67

 

 
67

 
 
$

 
$
67

 
$

 
$
67

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
Included below is a summary of the changes in our Level 3 fair value measurements (in thousands):
 
 
PFG Debt, net of discount
 
Warrant Debt
Balance at September 30, 2016
 
$
1,225

 
$
102

Activity during the current period:
 
 
 
 
   Payments to PFG
 
(605
)
 

   Change in fair value
 
55

 
15

Balance at June 30, 2017
 
$
675

 
$
117

 




Fair Value Assumptions for Stock Options Granted
The fair value of each option grant is estimated using the assumptions in the following table:
 
Nine Months Ended
June 30,
 
2017
 
2016
Expected life
4.8-4.9 years
 
4.9-5.0 years
Risk-free interest rate
1.08%-1.49%
 
0.85%-1.23%
Expected volatility
56.98%-61.88%
 
53.75%-56.61%
Expected forfeiture rate
10.17%-11.72%
 
10.61%-11.76%
Expected exercise factor
1.32-1.35
 
1.43-1.44
Expected dividend yield
0%
 
0%
Summary of Option Activity
A summary of option activity at June 30, 2017 and changes during the nine months then ended is presented below:
 
Options
 
Weighted-
Average
Exercise Price
 
Weighted-
Average
Remaining
Contractual
Period in
Years
Outstanding at October 1, 2016
1,602,822

 
$
9.51

 
6.6
Granted
315,020

 
4.75

 
9.5
Exercised

 

 
0.0
Forfeited
(84,314
)
 
16.81

 
4.9
Outstanding at June 30, 2017
1,833,528

 
8.36

 
6.1
Exercisable at June 30, 2017
1,265,843

 
9.21

 
5.0
Summary of Status of Company's Non-vested Shares
A summary of the status of the Company’s non-vested shares and changes during the nine month period ended June 30, 2017 is presented below:
 
2017
Non-vested Shares
Shares
 
Weighted-Average
Grant Date Fair
Value
Non-vested at October 1, 2016
539,985

 
$
3.21

Granted
315,020

 
1.83

Vested
(256,248
)
 
3.06

Forfeited
(31,072
)
 
2.58

Non-vested at June 30, 2017
567,685

 
$
2.50

Computation of Basic and Diluted Weighted Average Shares Used in Earnings Per Share Calculations
The following table sets forth the computation of basic and diluted weighted average shares used in the earnings per share calculations:
 
Three Months Ended
June 30,
Nine Months Ended
June 30,
 
2017
 
2016
2017
 
2016
Denominator for basic loss per share - weighted average common shares
4,449,893

 
4,402,479

4,429,006

 
4,381,987

Effect of dilutive options (treasury method)

 


 

Denominator for diluted loss per share - adjusted weighted average common shares
4,449,893

 
4,402,479

4,429,006

 
4,381,987

Options and warrants outstanding during each period, but not included in the computation of diluted loss per share because they are antidilutive
1,968,330

 
1,754,262

1,968,330

 
1,754,262